These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31397118)

  • 1. Knockdown of SP1/Syncytin1 axis inhibits the proliferation and metastasis through the AKT and ERK1/2 signaling pathways in non-small cell lung cancer.
    Li X; Fu Y; Xia X; Zhang X; Xiao K; Zhuang X; Zhang Y
    Cancer Med; 2019 Sep; 8(12):5750-5759. PubMed ID: 31397118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
    Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
    Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SSPH I, A Novel Anti-cancer Saponin, Inhibits EMT and Invasion and Migration of NSCLC by Suppressing MAPK/ERK1/2 and PI3K/AKT/ mTOR Signaling Pathways.
    Zhou J; Luo J; Gan R; Zhi L; Zhou H; Lv M; Huang Y; Liang G
    Recent Pat Anticancer Drug Discov; 2024; 19(4):543-555. PubMed ID: 38305308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of metastatic potential by inhibiting EGFR/Akt/p38/ERK signaling pathway and epithelial-mesenchymal transition after carbon ion exposure is potentiated by PARP-1 inhibition in non-small-cell lung cancer.
    Chowdhury P; Dey P; Ghosh S; Sarma A; Ghosh U
    BMC Cancer; 2019 Aug; 19(1):829. PubMed ID: 31438892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
    Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
    Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isorhamnetin inhibited migration and invasion via suppression of Akt/ERK-mediated epithelial-to-mesenchymal transition (EMT) in A549 human non-small-cell lung cancer cells.
    Luo W; Liu Q; Jiang N; Li M; Shi L
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31467176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.
    Jiang M; Zhou LY; Xu N; An Q
    Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking M2 muscarinic receptor signaling inhibits tumor growth and reverses epithelial-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC).
    Zhao Q; Gu X; Zhang C; Lu Q; Chen H; Xu L
    Cancer Biol Ther; 2015; 16(4):634-43. PubMed ID: 25778781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
    Tang Y; Xiao G; Chen Y; Deng Y
    Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 11. Emodin Increases Expression of Insulin-Like Growth Factor Binding Protein 1 through Activation of MEK/ERK/AMPKα and Interaction of PPARγ and Sp1 in Lung Cancer.
    Tang Q; Wu J; Zheng F; Hann SS; Chen Y
    Cell Physiol Biochem; 2017; 41(1):339-357. PubMed ID: 28214826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-elemene inhibited expression of DNA methyltransferase 1 through activation of ERK1/2 and AMPKα signalling pathways in human lung cancer cells: the role of Sp1.
    Zhao S; Wu J; Zheng F; Tang Q; Yang L; Li L; Wu W; Hann SS
    J Cell Mol Med; 2015 Mar; 19(3):630-41. PubMed ID: 25598321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC).
    Zhao Q; Yue J; Zhang C; Gu X; Chen H; Xu L
    Oncotarget; 2015 Oct; 6(30):29335-46. PubMed ID: 26336823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell adhesion molecule 4 suppresses cell growth and metastasis by inhibiting the Akt signaling pathway in non-small cell lung cancer.
    Luo F; Zhao Y; Liu J
    Int J Biochem Cell Biol; 2020 Jun; 123():105750. PubMed ID: 32325280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing the FOLR2 Gene Inhibits Cell Proliferation and Increases Apoptosis in the NCI-H1650 Non-Small Cell Lung Cancer Cell Line via Inhibition of AKT/Mammalian Target of Rapamycin (mTOR)/Ribosomal Protein S6 Kinase 1 (S6K1) Signaling.
    Xu X; Jiang J; Yao L; Ji B
    Med Sci Monit; 2018 Nov; 24():8064-8073. PubMed ID: 30415267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneous nuclear ribonucleoprotein A2/B1 regulates the ERK and p53/HDM2 signaling pathways to promote the survival, proliferation and migration of non‑small cell lung cancer cells.
    Kim MK; Choi MJ; Lee HM; Choi HS; Park YK; Ryu CJ
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34109989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
    Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
    Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YXQ-EQ Induces Apoptosis and Inhibits Signaling Pathways Important for Metastasis in Non-Small Cell Lung Carcinoma Cells.
    Yan X; Shen H; Jiang H; Hu D; Wang J; Wu X
    Cell Physiol Biochem; 2018; 49(3):911-919. PubMed ID: 30184531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ING5 inhibits lung cancer invasion and epithelial-mesenchymal transition by inhibiting the WNT/β-catenin pathway.
    Liu XL; Meng J; Zhang XT; Liang XH; Zhang F; Zhao GR; Zhang T
    Thorac Cancer; 2019 Apr; 10(4):848-855. PubMed ID: 30810286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.
    Liu LC; Tsao TC; Hsu SR; Wang HC; Tsai TC; Kao JY; Way TD
    J Agric Food Chem; 2012 Oct; 60(39):9863-73. PubMed ID: 22957988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.